ArticleThe oncologist2022

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.

Melinda L Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.